These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39045769)

  • 1. Improving insulin resistance by sulforaphane
    Tian S; Lei Y; Zhao F; Che J; Wu Y; Lei P; Kang YE; Shan Y
    Food Funct; 2024 Aug; 15(17):8644-8660. PubMed ID: 39045769
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of endoplasmic reticulum stress via sulforaphane-mediated AMPK upregulation against nonalcoholic fatty liver disease in rats.
    Mansour SZ; Moustafa EM; Moawed FSM
    Cell Stress Chaperones; 2022 Sep; 27(5):499-511. PubMed ID: 35779187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
    Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
    Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.
    Wu YK; Ren ZN; Zhu SL; Wu YZ; Wang G; Zhang H; Chen W; He Z; Ye XL; Zhai QX
    Acta Pharmacol Sin; 2022 Jun; 43(6):1473-1483. PubMed ID: 34654875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic action of the Chinese formula Shouhuitongbian and the underlying mechanism associated with alteration of gut microbiota.
    Wang T; Liao H; Lin J; Zhang M; Chen B; Yin R; Sun J; Dai H; Liu H
    Phytomedicine; 2024 Jul; 129():155575. PubMed ID: 38636179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut-Liver Axis.
    Xu Y; Huang X; Huangfu B; Hu Y; Xu J; Gao R; Huang K; He X
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis].
    Zou JJ; Li H; Zhou M; Huang QQ; Wu YJ; Yu R
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice.
    Chen H; Sun Y; Zhao H; Qi X; Cui H; Li Q; Ma Y
    Food Funct; 2022 Oct; 13(19):9878-9892. PubMed ID: 36052713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota.
    Lee YS; Lee D; Park GS; Ko SH; Park J; Lee YK; Kang J
    Food Funct; 2021 Jul; 12(14):6363-6373. PubMed ID: 34105563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
    Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
    Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
    Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
    Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
    Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet.
    Bi CR; Sun JT; Du J; Chu LY; Li YJ; Jia XY; Liu Y; Zhang WP; Li YC; Liu YJ
    Front Cell Infect Microbiol; 2022; 12():1005318. PubMed ID: 36683694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.